Improving the treatment of Epstein-Barr virus infectious mononucleosis in children

Journal Title: Актуальна інфектологія - Year 2018, Vol 6, Issue 2

Abstract

Background. In Ukraine, as in the whole world, there is a tendency to increase in the number of diffuse liver diseases. Increased percentage of patients with liver disease among adults is mostly determined by the damages to hepatobiliary system in childhood. The purpose of the study was to evaluate the effectiveness of ursodeoxycholic acid (UDCA) in the therapy of liver damages due to Epstein-Barr virus (EBV). Materials and methods. Research design: prospective, open-label, controlled. Sixty children with EBV infectious mononucleosis (IM) aged 1 to 18 years old were screened. All patients were observed, examined during the acute period of the disease, and divided into 2 groups. The children of the main group (n = 35) received standard therapy for EBV IM in combination with UDCA, patients of the control group (n = 25) received standard treatment alone. Results. Received data showed that therapy improved by means of UDCA in EBV IM and liver damage promotes a faster regression of the main symptoms of infection, such as fever, appetite loss and jaundice, already on day 7 from the beginning of treatment and a more rapid norma­lization of indicators of the functional state of the liver (alanine aminotransferase, bilirubin, alkaline phosphatase, gamma glutamyltransferase, lactate dehydrogenase). The drug was well tolerated, no adverse reactions were observed. Conclusions. The inclusion of UDCA in the treatment scheme can improve the effectiveness of advanced therapy compared with standard one, promotes a more rapid regression of infection symptoms and a more rapid norma­lization of indicators of the functional state of the liver.

Authors and Affiliations

S. O. Кramarov, V. O. Shadrin, V. V. Yevtushenko, I. V. Shpak, L. A. Bolshakova, Т. M. Kaminskaya

Keywords

Related Articles

Impact of Industrial Pollutant on Immune and Metabolic Status of Healthy Children Aged 12–14 Years Old Living in Various Industrial Areas of Luhansk Region

The study of factors affecting the health status remains one of the most urgent medical and social areas, especially in a society that has not yet overcome the tendency to reduce the standard of living, due to demographi...

Modern approaches to antibacterial therapy of acute intestinal infections

Acute intestinal infections remain an urgent problem of medicine due to the high level of morbidity and mortality. There are nearly 1.7 billion cases of childhood diarrhoeal diseases every year. Each year, diarrhoea kill...

Difficulties with the diagnosis of pain syndrome in a 16-year-old patient with herpes zoster (clinical case)

The article presents clinical observation of herpes zoster in a 16-year-old boy. Herpes zoster in this patient occurred without typical rash — zoster sine herpete. The main clinical symptom was pain, which caused certain...

Сучасні клініко-епідеміологічні особливості ентеровірусних менінгітів

Актуальність. Актуальність нейроінфекцій обумовлена вираженою тяжкістю перебігу та високим відсотком летальності. Кількість серозних менінгітів збільшується щодня. Серозний менінгіт є одним із найбільш частих проявів ент...

Follow-Up Study of Children with Mixed Rotavirus Infection

Introduction. Rotavirus infection is an actual problem of practical health care and the leading cause of viral diarrhea in children of early age [1]. Rotavirus infection in infants may occur as a combined form, and the l...

Download PDF file
  • EP ID EP289583
  • DOI 10.22141/2312-413x.6.2.2018.131095
  • Views 79
  • Downloads 0

How To Cite

S. O. Кramarov, V. O. Shadrin, V. V. Yevtushenko, I. V. Shpak, L. A. Bolshakova, Т. M. Kaminskaya (2018). Improving the treatment of Epstein-Barr virus infectious mononucleosis in children. Актуальна інфектологія, 6(2), 87-92. https://europub.co.uk/articles/-A-289583